Women’s perception of barriers and facilitators of cervical cancer Pap smear screening: a qualitative study

Author:

Shariati-Sarcheshme MansooreORCID,Mahdizdeh MehrsadatORCID,Tehrani HadiORCID,Jamali JamshidORCID,Vahedian-Shahroodi MohammadORCID

Abstract

ObjectiveAlthough Pap smear (PS) is considered the best standard in detecting cervical cancer, adherence to timely and regular PS is often lower than global standards in developing countries. Thus, the present study aimed to identify barriers and facilitators of adherence to cervical cancer screening in Mashhad, Iran.DesignA qualitative content analysis was done from July to December 2022 using semistructured in-depth interviews.SettingThe study was conducted in health centres in Mashhad, Iran.ParticipantsA sample of 36 married women aged 18–70 years was selected using a purposive sampling, with maximum diversity.ResultsThe mean age of participants was 42.8±7.6 years. Among all, 66.7% had the PS test at least once; only 8.3% regularly had the test. The qualitative content analysis led to the extraction of four major themes: (1) individual challenges, (2) environmental limitations, (3) individual motivators, and (4) supportive and efficient environments. The most significant barriers were psychological stress, unhealthy attitudes, insufficient information, cultural issues and insufficient healthcare services. Facilitators included an active and efficient healthcare system, advice and support of important others, and positive emotions and individual beliefs.ConclusionsParticipants' perceptions showed that the main factors influencing the PS testing were supportive environments, individual motivators, individual challenges and environmental limitations. To encourage women to take the PS and reduce barriers, it may be necessary to revise current health system policies, promote individual and public awareness, reduce psychological stress and correct negative beliefs and attitudes.

Publisher

BMJ

Reference43 articles.

1. TAaC L . Cervical cancer screening the International agency for research on cancer (IARC). 2022: 467.

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

3. The needs of women referring to health care centers for doing PAP smear tests;Fallahi;The Iranian Journal of Obstetrics, Gynecology and Infertility,2016

4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

5. WHO . Who. INT/teams/Noncommunicable diseases/surveillance/data/Cervical-cancer-profiles. 2022. Available: https://www.who.int/teams/noncommunicable-diseases/surveillance/data/cervical-cancer-profiles

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3